Global Endoparasiticide Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Endoparasiticide market size was valued at US$ million in 2023. With growing demand in downstream market, the Endoparasiticide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Endoparasiticide market. Endoparasiticide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Endoparasiticide. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Endoparasiticide market.
Key Features:
The report on Endoparasiticide market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Endoparasiticide market. It may include historical data, market segmentation by Type (e.g., Ear Tags, Tablets), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Endoparasiticide market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Endoparasiticide market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Endoparasiticide industry. This include advancements in Endoparasiticide technology, Endoparasiticide new entrants, Endoparasiticide new investment, and other innovations that are shaping the future of Endoparasiticide.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Endoparasiticide market. It includes factors influencing customer ' purchasing decisions, preferences for Endoparasiticide product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Endoparasiticide market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Endoparasiticide market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Endoparasiticide market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Endoparasiticide industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Endoparasiticide market.
Market Segmentation:
Endoparasiticide market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Endoparasiticide market?
What factors are driving Endoparasiticide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Endoparasiticide market opportunities vary by end market size?
How does Endoparasiticide break out type, application?
According to our LPI (LP Information) latest study, the global Endoparasiticide market size was valued at US$ million in 2023. With growing demand in downstream market, the Endoparasiticide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Endoparasiticide market. Endoparasiticide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Endoparasiticide. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Endoparasiticide market.
Key Features:
The report on Endoparasiticide market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Endoparasiticide market. It may include historical data, market segmentation by Type (e.g., Ear Tags, Tablets), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Endoparasiticide market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Endoparasiticide market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Endoparasiticide industry. This include advancements in Endoparasiticide technology, Endoparasiticide new entrants, Endoparasiticide new investment, and other innovations that are shaping the future of Endoparasiticide.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Endoparasiticide market. It includes factors influencing customer ' purchasing decisions, preferences for Endoparasiticide product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Endoparasiticide market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Endoparasiticide market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Endoparasiticide market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Endoparasiticide industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Endoparasiticide market.
Market Segmentation:
Endoparasiticide market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Ear Tags
- Tablets
- Injectables
- Feed Additives
- Veterinary Hospitals or Clinics
- Animal Farms
- Home Care Settings
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boehringer Ingelheim
- Elanco
- Zoetis
- Merck
- Virbac
- Novartis AG
- Ceva Sante Animlae
- Bayer AG
- Eli Lilly
- Vetoquinol
What is the 10-year outlook for the global Endoparasiticide market?
What factors are driving Endoparasiticide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Endoparasiticide market opportunities vary by end market size?
How does Endoparasiticide break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Endoparasiticide Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Endoparasiticide by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Endoparasiticide by Country/Region, 2019, 2023 & 2030
2.2 Endoparasiticide Segment by Type
2.2.1 Ear Tags
2.2.2 Tablets
2.2.3 Injectables
2.2.4 Feed Additives
2.3 Endoparasiticide Sales by Type
2.3.1 Global Endoparasiticide Sales Market Share by Type (2019-2024)
2.3.2 Global Endoparasiticide Revenue and Market Share by Type (2019-2024)
2.3.3 Global Endoparasiticide Sale Price by Type (2019-2024)
2.4 Endoparasiticide Segment by Application
2.4.1 Veterinary Hospitals or Clinics
2.4.2 Animal Farms
2.4.3 Home Care Settings
2.5 Endoparasiticide Sales by Application
2.5.1 Global Endoparasiticide Sale Market Share by Application (2019-2024)
2.5.2 Global Endoparasiticide Revenue and Market Share by Application (2019-2024)
2.5.3 Global Endoparasiticide Sale Price by Application (2019-2024)
3 GLOBAL ENDOPARASITICIDE BY COMPANY
3.1 Global Endoparasiticide Breakdown Data by Company
3.1.1 Global Endoparasiticide Annual Sales by Company (2019-2024)
3.1.2 Global Endoparasiticide Sales Market Share by Company (2019-2024)
3.2 Global Endoparasiticide Annual Revenue by Company (2019-2024)
3.2.1 Global Endoparasiticide Revenue by Company (2019-2024)
3.2.2 Global Endoparasiticide Revenue Market Share by Company (2019-2024)
3.3 Global Endoparasiticide Sale Price by Company
3.4 Key Manufacturers Endoparasiticide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Endoparasiticide Product Location Distribution
3.4.2 Players Endoparasiticide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ENDOPARASITICIDE BY GEOGRAPHIC REGION
4.1 World Historic Endoparasiticide Market Size by Geographic Region (2019-2024)
4.1.1 Global Endoparasiticide Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Endoparasiticide Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Endoparasiticide Market Size by Country/Region (2019-2024)
4.2.1 Global Endoparasiticide Annual Sales by Country/Region (2019-2024)
4.2.2 Global Endoparasiticide Annual Revenue by Country/Region (2019-2024)
4.3 Americas Endoparasiticide Sales Growth
4.4 APAC Endoparasiticide Sales Growth
4.5 Europe Endoparasiticide Sales Growth
4.6 Middle East & Africa Endoparasiticide Sales Growth
5 AMERICAS
5.1 Americas Endoparasiticide Sales by Country
5.1.1 Americas Endoparasiticide Sales by Country (2019-2024)
5.1.2 Americas Endoparasiticide Revenue by Country (2019-2024)
5.2 Americas Endoparasiticide Sales by Type
5.3 Americas Endoparasiticide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Endoparasiticide Sales by Region
6.1.1 APAC Endoparasiticide Sales by Region (2019-2024)
6.1.2 APAC Endoparasiticide Revenue by Region (2019-2024)
6.2 APAC Endoparasiticide Sales by Type
6.3 APAC Endoparasiticide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Endoparasiticide by Country
7.1.1 Europe Endoparasiticide Sales by Country (2019-2024)
7.1.2 Europe Endoparasiticide Revenue by Country (2019-2024)
7.2 Europe Endoparasiticide Sales by Type
7.3 Europe Endoparasiticide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Endoparasiticide by Country
8.1.1 Middle East & Africa Endoparasiticide Sales by Country (2019-2024)
8.1.2 Middle East & Africa Endoparasiticide Revenue by Country (2019-2024)
8.2 Middle East & Africa Endoparasiticide Sales by Type
8.3 Middle East & Africa Endoparasiticide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Endoparasiticide
10.3 Manufacturing Process Analysis of Endoparasiticide
10.4 Industry Chain Structure of Endoparasiticide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Endoparasiticide Distributors
11.3 Endoparasiticide Customer
12 WORLD FORECAST REVIEW FOR ENDOPARASITICIDE BY GEOGRAPHIC REGION
12.1 Global Endoparasiticide Market Size Forecast by Region
12.1.1 Global Endoparasiticide Forecast by Region (2025-2030)
12.1.2 Global Endoparasiticide Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Endoparasiticide Forecast by Type
12.7 Global Endoparasiticide Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Endoparasiticide Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Elanco
13.2.1 Elanco Company Information
13.2.2 Elanco Endoparasiticide Product Portfolios and Specifications
13.2.3 Elanco Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Elanco Main Business Overview
13.2.5 Elanco Latest Developments
13.3 Zoetis
13.3.1 Zoetis Company Information
13.3.2 Zoetis Endoparasiticide Product Portfolios and Specifications
13.3.3 Zoetis Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Zoetis Main Business Overview
13.3.5 Zoetis Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Endoparasiticide Product Portfolios and Specifications
13.4.3 Merck Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Endoparasiticide Product Portfolios and Specifications
13.5.3 Virbac Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 Novartis AG
13.6.1 Novartis AG Company Information
13.6.2 Novartis AG Endoparasiticide Product Portfolios and Specifications
13.6.3 Novartis AG Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Novartis AG Main Business Overview
13.6.5 Novartis AG Latest Developments
13.7 Ceva Sante Animlae
13.7.1 Ceva Sante Animlae Company Information
13.7.2 Ceva Sante Animlae Endoparasiticide Product Portfolios and Specifications
13.7.3 Ceva Sante Animlae Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Ceva Sante Animlae Main Business Overview
13.7.5 Ceva Sante Animlae Latest Developments
13.8 Bayer AG
13.8.1 Bayer AG Company Information
13.8.2 Bayer AG Endoparasiticide Product Portfolios and Specifications
13.8.3 Bayer AG Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Bayer AG Main Business Overview
13.8.5 Bayer AG Latest Developments
13.9 Eli Lilly
13.9.1 Eli Lilly Company Information
13.9.2 Eli Lilly Endoparasiticide Product Portfolios and Specifications
13.9.3 Eli Lilly Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Eli Lilly Main Business Overview
13.9.5 Eli Lilly Latest Developments
13.10 Vetoquinol
13.10.1 Vetoquinol Company Information
13.10.2 Vetoquinol Endoparasiticide Product Portfolios and Specifications
13.10.3 Vetoquinol Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Vetoquinol Main Business Overview
13.10.5 Vetoquinol Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Endoparasiticide Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Endoparasiticide by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Endoparasiticide by Country/Region, 2019, 2023 & 2030
2.2 Endoparasiticide Segment by Type
2.2.1 Ear Tags
2.2.2 Tablets
2.2.3 Injectables
2.2.4 Feed Additives
2.3 Endoparasiticide Sales by Type
2.3.1 Global Endoparasiticide Sales Market Share by Type (2019-2024)
2.3.2 Global Endoparasiticide Revenue and Market Share by Type (2019-2024)
2.3.3 Global Endoparasiticide Sale Price by Type (2019-2024)
2.4 Endoparasiticide Segment by Application
2.4.1 Veterinary Hospitals or Clinics
2.4.2 Animal Farms
2.4.3 Home Care Settings
2.5 Endoparasiticide Sales by Application
2.5.1 Global Endoparasiticide Sale Market Share by Application (2019-2024)
2.5.2 Global Endoparasiticide Revenue and Market Share by Application (2019-2024)
2.5.3 Global Endoparasiticide Sale Price by Application (2019-2024)
3 GLOBAL ENDOPARASITICIDE BY COMPANY
3.1 Global Endoparasiticide Breakdown Data by Company
3.1.1 Global Endoparasiticide Annual Sales by Company (2019-2024)
3.1.2 Global Endoparasiticide Sales Market Share by Company (2019-2024)
3.2 Global Endoparasiticide Annual Revenue by Company (2019-2024)
3.2.1 Global Endoparasiticide Revenue by Company (2019-2024)
3.2.2 Global Endoparasiticide Revenue Market Share by Company (2019-2024)
3.3 Global Endoparasiticide Sale Price by Company
3.4 Key Manufacturers Endoparasiticide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Endoparasiticide Product Location Distribution
3.4.2 Players Endoparasiticide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ENDOPARASITICIDE BY GEOGRAPHIC REGION
4.1 World Historic Endoparasiticide Market Size by Geographic Region (2019-2024)
4.1.1 Global Endoparasiticide Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Endoparasiticide Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Endoparasiticide Market Size by Country/Region (2019-2024)
4.2.1 Global Endoparasiticide Annual Sales by Country/Region (2019-2024)
4.2.2 Global Endoparasiticide Annual Revenue by Country/Region (2019-2024)
4.3 Americas Endoparasiticide Sales Growth
4.4 APAC Endoparasiticide Sales Growth
4.5 Europe Endoparasiticide Sales Growth
4.6 Middle East & Africa Endoparasiticide Sales Growth
5 AMERICAS
5.1 Americas Endoparasiticide Sales by Country
5.1.1 Americas Endoparasiticide Sales by Country (2019-2024)
5.1.2 Americas Endoparasiticide Revenue by Country (2019-2024)
5.2 Americas Endoparasiticide Sales by Type
5.3 Americas Endoparasiticide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Endoparasiticide Sales by Region
6.1.1 APAC Endoparasiticide Sales by Region (2019-2024)
6.1.2 APAC Endoparasiticide Revenue by Region (2019-2024)
6.2 APAC Endoparasiticide Sales by Type
6.3 APAC Endoparasiticide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Endoparasiticide by Country
7.1.1 Europe Endoparasiticide Sales by Country (2019-2024)
7.1.2 Europe Endoparasiticide Revenue by Country (2019-2024)
7.2 Europe Endoparasiticide Sales by Type
7.3 Europe Endoparasiticide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Endoparasiticide by Country
8.1.1 Middle East & Africa Endoparasiticide Sales by Country (2019-2024)
8.1.2 Middle East & Africa Endoparasiticide Revenue by Country (2019-2024)
8.2 Middle East & Africa Endoparasiticide Sales by Type
8.3 Middle East & Africa Endoparasiticide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Endoparasiticide
10.3 Manufacturing Process Analysis of Endoparasiticide
10.4 Industry Chain Structure of Endoparasiticide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Endoparasiticide Distributors
11.3 Endoparasiticide Customer
12 WORLD FORECAST REVIEW FOR ENDOPARASITICIDE BY GEOGRAPHIC REGION
12.1 Global Endoparasiticide Market Size Forecast by Region
12.1.1 Global Endoparasiticide Forecast by Region (2025-2030)
12.1.2 Global Endoparasiticide Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Endoparasiticide Forecast by Type
12.7 Global Endoparasiticide Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Endoparasiticide Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Elanco
13.2.1 Elanco Company Information
13.2.2 Elanco Endoparasiticide Product Portfolios and Specifications
13.2.3 Elanco Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Elanco Main Business Overview
13.2.5 Elanco Latest Developments
13.3 Zoetis
13.3.1 Zoetis Company Information
13.3.2 Zoetis Endoparasiticide Product Portfolios and Specifications
13.3.3 Zoetis Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Zoetis Main Business Overview
13.3.5 Zoetis Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Endoparasiticide Product Portfolios and Specifications
13.4.3 Merck Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Endoparasiticide Product Portfolios and Specifications
13.5.3 Virbac Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 Novartis AG
13.6.1 Novartis AG Company Information
13.6.2 Novartis AG Endoparasiticide Product Portfolios and Specifications
13.6.3 Novartis AG Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Novartis AG Main Business Overview
13.6.5 Novartis AG Latest Developments
13.7 Ceva Sante Animlae
13.7.1 Ceva Sante Animlae Company Information
13.7.2 Ceva Sante Animlae Endoparasiticide Product Portfolios and Specifications
13.7.3 Ceva Sante Animlae Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Ceva Sante Animlae Main Business Overview
13.7.5 Ceva Sante Animlae Latest Developments
13.8 Bayer AG
13.8.1 Bayer AG Company Information
13.8.2 Bayer AG Endoparasiticide Product Portfolios and Specifications
13.8.3 Bayer AG Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Bayer AG Main Business Overview
13.8.5 Bayer AG Latest Developments
13.9 Eli Lilly
13.9.1 Eli Lilly Company Information
13.9.2 Eli Lilly Endoparasiticide Product Portfolios and Specifications
13.9.3 Eli Lilly Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Eli Lilly Main Business Overview
13.9.5 Eli Lilly Latest Developments
13.10 Vetoquinol
13.10.1 Vetoquinol Company Information
13.10.2 Vetoquinol Endoparasiticide Product Portfolios and Specifications
13.10.3 Vetoquinol Endoparasiticide Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Vetoquinol Main Business Overview
13.10.5 Vetoquinol Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
.
Table 1. Endoparasiticide Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Endoparasiticide Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Ear Tags
Table 4. Major Players of Tablets
Table 5. Major Players of Injectables
Table 6. Major Players of Feed Additives
Table 7. Global Endoparasiticide Sales by Type (2019-2024) & (K Units)
Table 8. Global Endoparasiticide Sales Market Share by Type (2019-2024)
Table 9. Global Endoparasiticide Revenue by Type (2019-2024) & ($ million)
Table 10. Global Endoparasiticide Revenue Market Share by Type (2019-2024)
Table 11. Global Endoparasiticide Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Endoparasiticide Sales by Application (2019-2024) & (K Units)
Table 13. Global Endoparasiticide Sales Market Share by Application (2019-2024)
Table 14. Global Endoparasiticide Revenue by Application (2019-2024)
Table 15. Global Endoparasiticide Revenue Market Share by Application (2019-2024)
Table 16. Global Endoparasiticide Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Endoparasiticide Sales by Company (2019-2024) & (K Units)
Table 18. Global Endoparasiticide Sales Market Share by Company (2019-2024)
Table 19. Global Endoparasiticide Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Endoparasiticide Revenue Market Share by Company (2019-2024)
Table 21. Global Endoparasiticide Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Endoparasiticide Producing Area Distribution and Sales Area
Table 23. Players Endoparasiticide Products Offered
Table 24. Endoparasiticide Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Endoparasiticide Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Endoparasiticide Sales Market Share Geographic Region (2019-2024)
Table 29. Global Endoparasiticide Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Endoparasiticide Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Endoparasiticide Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Endoparasiticide Sales Market Share by Country/Region (2019-2024)
Table 33. Global Endoparasiticide Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Endoparasiticide Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Endoparasiticide Sales by Country (2019-2024) & (K Units)
Table 36. Americas Endoparasiticide Sales Market Share by Country (2019-2024)
Table 37. Americas Endoparasiticide Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Endoparasiticide Revenue Market Share by Country (2019-2024)
Table 39. Americas Endoparasiticide Sales by Type (2019-2024) & (K Units)
Table 40. Americas Endoparasiticide Sales by Application (2019-2024) & (K Units)
Table 41. APAC Endoparasiticide Sales by Region (2019-2024) & (K Units)
Table 42. APAC Endoparasiticide Sales Market Share by Region (2019-2024)
Table 43. APAC Endoparasiticide Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Endoparasiticide Revenue Market Share by Region (2019-2024)
Table 45. APAC Endoparasiticide Sales by Type (2019-2024) & (K Units)
Table 46. APAC Endoparasiticide Sales by Application (2019-2024) & (K Units)
Table 47. Europe Endoparasiticide Sales by Country (2019-2024) & (K Units)
Table 48. Europe Endoparasiticide Sales Market Share by Country (2019-2024)
Table 49. Europe Endoparasiticide Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Endoparasiticide Revenue Market Share by Country (2019-2024)
Table 51. Europe Endoparasiticide Sales by Type (2019-2024) & (K Units)
Table 52. Europe Endoparasiticide Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Endoparasiticide Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Endoparasiticide Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Endoparasiticide Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Endoparasiticide Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Endoparasiticide Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Endoparasiticide Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Endoparasiticide
Table 60. Key Market Challenges & Risks of Endoparasiticide
Table 61. Key Industry Trends of Endoparasiticide
Table 62. Endoparasiticide Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Endoparasiticide Distributors List
Table 65. Endoparasiticide Customer List
Table 66. Global Endoparasiticide Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Endoparasiticide Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Endoparasiticide Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Endoparasiticide Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Endoparasiticide Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Endoparasiticide Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Endoparasiticide Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Endoparasiticide Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Endoparasiticide Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Endoparasiticide Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Endoparasiticide Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Endoparasiticide Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Endoparasiticide Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Endoparasiticide Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Boehringer Ingelheim Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 81. Boehringer Ingelheim Endoparasiticide Product Portfolios and Specifications
Table 82. Boehringer Ingelheim Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Boehringer Ingelheim Main Business
Table 84. Boehringer Ingelheim Latest Developments
Table 85. Elanco Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 86. Elanco Endoparasiticide Product Portfolios and Specifications
Table 87. Elanco Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Elanco Main Business
Table 89. Elanco Latest Developments
Table 90. Zoetis Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 91. Zoetis Endoparasiticide Product Portfolios and Specifications
Table 92. Zoetis Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Zoetis Main Business
Table 94. Zoetis Latest Developments
Table 95. Merck Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 96. Merck Endoparasiticide Product Portfolios and Specifications
Table 97. Merck Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Merck Main Business
Table 99. Merck Latest Developments
Table 100. Virbac Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 101. Virbac Endoparasiticide Product Portfolios and Specifications
Table 102. Virbac Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Virbac Main Business
Table 104. Virbac Latest Developments
Table 105. Novartis AG Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 106. Novartis AG Endoparasiticide Product Portfolios and Specifications
Table 107. Novartis AG Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Novartis AG Main Business
Table 109. Novartis AG Latest Developments
Table 110. Ceva Sante Animlae Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 111. Ceva Sante Animlae Endoparasiticide Product Portfolios and Specifications
Table 112. Ceva Sante Animlae Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Ceva Sante Animlae Main Business
Table 114. Ceva Sante Animlae Latest Developments
Table 115. Bayer AG Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 116. Bayer AG Endoparasiticide Product Portfolios and Specifications
Table 117. Bayer AG Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Bayer AG Main Business
Table 119. Bayer AG Latest Developments
Table 120. Eli Lilly Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 121. Eli Lilly Endoparasiticide Product Portfolios and Specifications
Table 122. Eli Lilly Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Eli Lilly Main Business
Table 124. Eli Lilly Latest Developments
Table 125. Vetoquinol Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 126. Vetoquinol Endoparasiticide Product Portfolios and Specifications
Table 127. Vetoquinol Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Vetoquinol Main Business
Table 129. Vetoquinol Latest Developments
.
Table 1. Endoparasiticide Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Endoparasiticide Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Ear Tags
Table 4. Major Players of Tablets
Table 5. Major Players of Injectables
Table 6. Major Players of Feed Additives
Table 7. Global Endoparasiticide Sales by Type (2019-2024) & (K Units)
Table 8. Global Endoparasiticide Sales Market Share by Type (2019-2024)
Table 9. Global Endoparasiticide Revenue by Type (2019-2024) & ($ million)
Table 10. Global Endoparasiticide Revenue Market Share by Type (2019-2024)
Table 11. Global Endoparasiticide Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Endoparasiticide Sales by Application (2019-2024) & (K Units)
Table 13. Global Endoparasiticide Sales Market Share by Application (2019-2024)
Table 14. Global Endoparasiticide Revenue by Application (2019-2024)
Table 15. Global Endoparasiticide Revenue Market Share by Application (2019-2024)
Table 16. Global Endoparasiticide Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Endoparasiticide Sales by Company (2019-2024) & (K Units)
Table 18. Global Endoparasiticide Sales Market Share by Company (2019-2024)
Table 19. Global Endoparasiticide Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Endoparasiticide Revenue Market Share by Company (2019-2024)
Table 21. Global Endoparasiticide Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Endoparasiticide Producing Area Distribution and Sales Area
Table 23. Players Endoparasiticide Products Offered
Table 24. Endoparasiticide Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Endoparasiticide Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Endoparasiticide Sales Market Share Geographic Region (2019-2024)
Table 29. Global Endoparasiticide Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Endoparasiticide Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Endoparasiticide Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Endoparasiticide Sales Market Share by Country/Region (2019-2024)
Table 33. Global Endoparasiticide Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Endoparasiticide Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Endoparasiticide Sales by Country (2019-2024) & (K Units)
Table 36. Americas Endoparasiticide Sales Market Share by Country (2019-2024)
Table 37. Americas Endoparasiticide Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Endoparasiticide Revenue Market Share by Country (2019-2024)
Table 39. Americas Endoparasiticide Sales by Type (2019-2024) & (K Units)
Table 40. Americas Endoparasiticide Sales by Application (2019-2024) & (K Units)
Table 41. APAC Endoparasiticide Sales by Region (2019-2024) & (K Units)
Table 42. APAC Endoparasiticide Sales Market Share by Region (2019-2024)
Table 43. APAC Endoparasiticide Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Endoparasiticide Revenue Market Share by Region (2019-2024)
Table 45. APAC Endoparasiticide Sales by Type (2019-2024) & (K Units)
Table 46. APAC Endoparasiticide Sales by Application (2019-2024) & (K Units)
Table 47. Europe Endoparasiticide Sales by Country (2019-2024) & (K Units)
Table 48. Europe Endoparasiticide Sales Market Share by Country (2019-2024)
Table 49. Europe Endoparasiticide Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Endoparasiticide Revenue Market Share by Country (2019-2024)
Table 51. Europe Endoparasiticide Sales by Type (2019-2024) & (K Units)
Table 52. Europe Endoparasiticide Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Endoparasiticide Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Endoparasiticide Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Endoparasiticide Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Endoparasiticide Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Endoparasiticide Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Endoparasiticide Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Endoparasiticide
Table 60. Key Market Challenges & Risks of Endoparasiticide
Table 61. Key Industry Trends of Endoparasiticide
Table 62. Endoparasiticide Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Endoparasiticide Distributors List
Table 65. Endoparasiticide Customer List
Table 66. Global Endoparasiticide Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Endoparasiticide Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Endoparasiticide Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Endoparasiticide Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Endoparasiticide Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Endoparasiticide Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Endoparasiticide Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Endoparasiticide Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Endoparasiticide Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Endoparasiticide Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Endoparasiticide Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Endoparasiticide Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Endoparasiticide Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Endoparasiticide Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Boehringer Ingelheim Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 81. Boehringer Ingelheim Endoparasiticide Product Portfolios and Specifications
Table 82. Boehringer Ingelheim Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Boehringer Ingelheim Main Business
Table 84. Boehringer Ingelheim Latest Developments
Table 85. Elanco Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 86. Elanco Endoparasiticide Product Portfolios and Specifications
Table 87. Elanco Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Elanco Main Business
Table 89. Elanco Latest Developments
Table 90. Zoetis Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 91. Zoetis Endoparasiticide Product Portfolios and Specifications
Table 92. Zoetis Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Zoetis Main Business
Table 94. Zoetis Latest Developments
Table 95. Merck Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 96. Merck Endoparasiticide Product Portfolios and Specifications
Table 97. Merck Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Merck Main Business
Table 99. Merck Latest Developments
Table 100. Virbac Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 101. Virbac Endoparasiticide Product Portfolios and Specifications
Table 102. Virbac Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Virbac Main Business
Table 104. Virbac Latest Developments
Table 105. Novartis AG Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 106. Novartis AG Endoparasiticide Product Portfolios and Specifications
Table 107. Novartis AG Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Novartis AG Main Business
Table 109. Novartis AG Latest Developments
Table 110. Ceva Sante Animlae Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 111. Ceva Sante Animlae Endoparasiticide Product Portfolios and Specifications
Table 112. Ceva Sante Animlae Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Ceva Sante Animlae Main Business
Table 114. Ceva Sante Animlae Latest Developments
Table 115. Bayer AG Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 116. Bayer AG Endoparasiticide Product Portfolios and Specifications
Table 117. Bayer AG Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Bayer AG Main Business
Table 119. Bayer AG Latest Developments
Table 120. Eli Lilly Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 121. Eli Lilly Endoparasiticide Product Portfolios and Specifications
Table 122. Eli Lilly Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Eli Lilly Main Business
Table 124. Eli Lilly Latest Developments
Table 125. Vetoquinol Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors
Table 126. Vetoquinol Endoparasiticide Product Portfolios and Specifications
Table 127. Vetoquinol Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Vetoquinol Main Business
Table 129. Vetoquinol Latest Developments
LIST OF FIGURES
.
Figure 1. Picture of Endoparasiticide
Figure 2. Endoparasiticide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Endoparasiticide Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Endoparasiticide Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Endoparasiticide Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Ear Tags
Figure 10. Product Picture of Tablets
Figure 11. Product Picture of Injectables
Figure 12. Product Picture of Feed Additives
Figure 13. Global Endoparasiticide Sales Market Share by Type in 2023
Figure 14. Global Endoparasiticide Revenue Market Share by Type (2019-2024)
Figure 15. Endoparasiticide Consumed in Veterinary Hospitals or Clinics
Figure 16. Global Endoparasiticide Market: Veterinary Hospitals or Clinics (2019-2024) & (K Units)
Figure 17. Endoparasiticide Consumed in Animal Farms
Figure 18. Global Endoparasiticide Market: Animal Farms (2019-2024) & (K Units)
Figure 19. Endoparasiticide Consumed in Home Care Settings
Figure 20. Global Endoparasiticide Market: Home Care Settings (2019-2024) & (K Units)
Figure 21. Global Endoparasiticide Sales Market Share by Application (2023)
Figure 22. Global Endoparasiticide Revenue Market Share by Application in 2023
Figure 23. Endoparasiticide Sales Market by Company in 2023 (K Units)
Figure 24. Global Endoparasiticide Sales Market Share by Company in 2023
Figure 25. Endoparasiticide Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Endoparasiticide Revenue Market Share by Company in 2023
Figure 27. Global Endoparasiticide Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Endoparasiticide Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Endoparasiticide Sales 2019-2024 (K Units)
Figure 30. Americas Endoparasiticide Revenue 2019-2024 ($ Millions)
Figure 31. APAC Endoparasiticide Sales 2019-2024 (K Units)
Figure 32. APAC Endoparasiticide Revenue 2019-2024 ($ Millions)
Figure 33. Europe Endoparasiticide Sales 2019-2024 (K Units)
Figure 34. Europe Endoparasiticide Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Endoparasiticide Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Endoparasiticide Revenue 2019-2024 ($ Millions)
Figure 37. Americas Endoparasiticide Sales Market Share by Country in 2023
Figure 38. Americas Endoparasiticide Revenue Market Share by Country in 2023
Figure 39. Americas Endoparasiticide Sales Market Share by Type (2019-2024)
Figure 40. Americas Endoparasiticide Sales Market Share by Application (2019-2024)
Figure 41. United States Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Endoparasiticide Sales Market Share by Region in 2023
Figure 46. APAC Endoparasiticide Revenue Market Share by Regions in 2023
Figure 47. APAC Endoparasiticide Sales Market Share by Type (2019-2024)
Figure 48. APAC Endoparasiticide Sales Market Share by Application (2019-2024)
Figure 49. China Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Endoparasiticide Sales Market Share by Country in 2023
Figure 57. Europe Endoparasiticide Revenue Market Share by Country in 2023
Figure 58. Europe Endoparasiticide Sales Market Share by Type (2019-2024)
Figure 59. Europe Endoparasiticide Sales Market Share by Application (2019-2024)
Figure 60. Germany Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Endoparasiticide Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Endoparasiticide Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Endoparasiticide Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Endoparasiticide Sales Market Share by Application (2019-2024)
Figure 69. Egypt Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Endoparasiticide in 2023
Figure 75. Manufacturing Process Analysis of Endoparasiticide
Figure 76. Industry Chain Structure of Endoparasiticide
Figure 77. Channels of Distribution
Figure 78. Global Endoparasiticide Sales Market Forecast by Region (2025-2030)
Figure 79. Global Endoparasiticide Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Endoparasiticide Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Endoparasiticide Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Endoparasiticide Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Endoparasiticide Revenue Market Share Forecast by Application (2025-2030)
.
Figure 1. Picture of Endoparasiticide
Figure 2. Endoparasiticide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Endoparasiticide Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Endoparasiticide Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Endoparasiticide Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Ear Tags
Figure 10. Product Picture of Tablets
Figure 11. Product Picture of Injectables
Figure 12. Product Picture of Feed Additives
Figure 13. Global Endoparasiticide Sales Market Share by Type in 2023
Figure 14. Global Endoparasiticide Revenue Market Share by Type (2019-2024)
Figure 15. Endoparasiticide Consumed in Veterinary Hospitals or Clinics
Figure 16. Global Endoparasiticide Market: Veterinary Hospitals or Clinics (2019-2024) & (K Units)
Figure 17. Endoparasiticide Consumed in Animal Farms
Figure 18. Global Endoparasiticide Market: Animal Farms (2019-2024) & (K Units)
Figure 19. Endoparasiticide Consumed in Home Care Settings
Figure 20. Global Endoparasiticide Market: Home Care Settings (2019-2024) & (K Units)
Figure 21. Global Endoparasiticide Sales Market Share by Application (2023)
Figure 22. Global Endoparasiticide Revenue Market Share by Application in 2023
Figure 23. Endoparasiticide Sales Market by Company in 2023 (K Units)
Figure 24. Global Endoparasiticide Sales Market Share by Company in 2023
Figure 25. Endoparasiticide Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Endoparasiticide Revenue Market Share by Company in 2023
Figure 27. Global Endoparasiticide Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Endoparasiticide Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Endoparasiticide Sales 2019-2024 (K Units)
Figure 30. Americas Endoparasiticide Revenue 2019-2024 ($ Millions)
Figure 31. APAC Endoparasiticide Sales 2019-2024 (K Units)
Figure 32. APAC Endoparasiticide Revenue 2019-2024 ($ Millions)
Figure 33. Europe Endoparasiticide Sales 2019-2024 (K Units)
Figure 34. Europe Endoparasiticide Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Endoparasiticide Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Endoparasiticide Revenue 2019-2024 ($ Millions)
Figure 37. Americas Endoparasiticide Sales Market Share by Country in 2023
Figure 38. Americas Endoparasiticide Revenue Market Share by Country in 2023
Figure 39. Americas Endoparasiticide Sales Market Share by Type (2019-2024)
Figure 40. Americas Endoparasiticide Sales Market Share by Application (2019-2024)
Figure 41. United States Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Endoparasiticide Sales Market Share by Region in 2023
Figure 46. APAC Endoparasiticide Revenue Market Share by Regions in 2023
Figure 47. APAC Endoparasiticide Sales Market Share by Type (2019-2024)
Figure 48. APAC Endoparasiticide Sales Market Share by Application (2019-2024)
Figure 49. China Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Endoparasiticide Sales Market Share by Country in 2023
Figure 57. Europe Endoparasiticide Revenue Market Share by Country in 2023
Figure 58. Europe Endoparasiticide Sales Market Share by Type (2019-2024)
Figure 59. Europe Endoparasiticide Sales Market Share by Application (2019-2024)
Figure 60. Germany Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Endoparasiticide Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Endoparasiticide Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Endoparasiticide Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Endoparasiticide Sales Market Share by Application (2019-2024)
Figure 69. Egypt Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Endoparasiticide Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Endoparasiticide in 2023
Figure 75. Manufacturing Process Analysis of Endoparasiticide
Figure 76. Industry Chain Structure of Endoparasiticide
Figure 77. Channels of Distribution
Figure 78. Global Endoparasiticide Sales Market Forecast by Region (2025-2030)
Figure 79. Global Endoparasiticide Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Endoparasiticide Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Endoparasiticide Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Endoparasiticide Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Endoparasiticide Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Diabetic Assays Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
86 pages
Global Surgical Protective Mask Market Growth 2023-2029
US$ 3,660.00
February 2023
105 pages
Global Intensive Care Unit Equipment (COVID-19) Market Growth 2023-2029
US$ 3,660.00
March 2023
118 pages
Global Hydrocephalus Shunts Market Growth 2026-2032
US$ 3,660.00
January 2025
76 pages
Global Herpes Simplex Virus Infections Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
110 pages
